Matošević, A.; Knežević, A.; Zandona, A.; Maraković, N.; Kovarik, Z.; Bosak, A.
Design, Synthesis and Biological Evaluation of Biscarbamates as Potential Selective Butyrylcholinesterase Inhibitors for the Treatment of Alzheimer’s Disease. Pharmaceuticals 2022, 15, 1220.
https://doi.org/10.3390/ph15101220
AMA Style
Matošević A, Knežević A, Zandona A, Maraković N, Kovarik Z, Bosak A.
Design, Synthesis and Biological Evaluation of Biscarbamates as Potential Selective Butyrylcholinesterase Inhibitors for the Treatment of Alzheimer’s Disease. Pharmaceuticals. 2022; 15(10):1220.
https://doi.org/10.3390/ph15101220
Chicago/Turabian Style
Matošević, Ana, Anamarija Knežević, Antonio Zandona, Nikola Maraković, Zrinka Kovarik, and Anita Bosak.
2022. "Design, Synthesis and Biological Evaluation of Biscarbamates as Potential Selective Butyrylcholinesterase Inhibitors for the Treatment of Alzheimer’s Disease" Pharmaceuticals 15, no. 10: 1220.
https://doi.org/10.3390/ph15101220
APA Style
Matošević, A., Knežević, A., Zandona, A., Maraković, N., Kovarik, Z., & Bosak, A.
(2022). Design, Synthesis and Biological Evaluation of Biscarbamates as Potential Selective Butyrylcholinesterase Inhibitors for the Treatment of Alzheimer’s Disease. Pharmaceuticals, 15(10), 1220.
https://doi.org/10.3390/ph15101220